Unique ID issued by UMIN | UMIN000029616 |
---|---|
Receipt number | R000033832 |
Scientific Title | Suppression effect on tooth staining evaluated in the newly developed tea beverage/ Randomized controlled trials with double blind crossover study |
Date of disclosure of the study information | 2017/10/18 |
Last modified on | 2018/07/10 19:24:03 |
Suppression effect on tooth staining evaluated in the newly developed tea beverage/ Randomized controlled trials with double blind crossover study
Suppression effect on tooth staining evaluated in the newly developed tea beverage
Suppression effect on tooth staining evaluated in the newly developed tea beverage/ Randomized controlled trials with double blind crossover study
Suppression effect on tooth staining evaluated in the newly developed tea beverage
Japan |
None (Healthy adults)
Adult |
Others
NO
Evaluate suppression effect on tooth staining after having tea for 3 weeks.
Efficacy
Tooth staining
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Drink the test tea once a day for 3 weeks followed by washout-period, after which drink the placebo tea once a day for 3 weeks.
Drink the placebo tea once a day for 3 weeks followed by washout-period, after which drink the test tea once a day for 3 weeks.
18 | years-old | <= |
29 | years-old | >= |
Female
1)Japanese Females aged from 18 to 29, when giving the informed consent.
(2)Subjects who never smoke tobacco.
1. Subjects who are judged as unsuitable for lifestyle questionnaires.
2. Subjects who may have allergy to test foods.
3. Subjects with big covered product or fillings of the front teeth.
4. Subjects who have chronic diseases requiring regular administration, or who have severe diseases.
5. Subjects who have a medical history of serious disease e.g., diabetes, liver disease, kidney disease, and/or heart disease, thyroid gland disease, adrenal gland disease, and/or metabolic disorder.
6. Individuals who have a medical history of diseases affecting digestion and absorption.
7.Subjects who have participated other clinical studies within 1 month of giving the informed consent or who are planning to participate other clinical studies during this study.
8. Subjects who have a medical history of drug. dependence or alcohol dependence.
9. Subjects who are or willing to be pregnant, or who are breast-feeding during this study.
10. Subjects who are planning to have dental work done during this study.
11.Subjects who work in a company developing or manufacturing functional foods.
12. Subjects who are judged as unsuitable by doctor for other reasons.
14
1st name | |
Middle name | |
Last name | Yasuko Momoi |
Tsurumi University
School of Dental Medicine Department of Operative Dentistry
2-1-3 Tsurumi Tsurumi-ku Yokohama Kanagawa, Japan
045-580-8426
momoi-y@tsurumi-u.ac.jp
1st name | |
Middle name | |
Last name | Kaoru Ohmori |
Tsurumi University
School of Dental Medicine Department of Operative Dentistry
2-1-3 Tsurumi Tsurumi-ku Yokohama Kanagawa, Japan
045-580-8427
omori-k@tsurumi-u.ac.jp
Tsurumi University
Kirin Company, Limited
Profit organization
NO
2017 | Year | 10 | Month | 18 | Day |
Unpublished
Preinitiation
2017 | Year | 09 | Month | 19 | Day |
2017 | Year | 10 | Month | 23 | Day |
2018 | Year | 05 | Month | 24 | Day |
2018 | Year | 05 | Month | 24 | Day |
2018 | Year | 07 | Month | 02 | Day |
2018 | Year | 07 | Month | 04 | Day |
2017 | Year | 10 | Month | 18 | Day |
2018 | Year | 07 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033832